vs
Carter Bankshares, Inc.（CARE）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Carter Bankshares, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.1倍（$39.8M vs $35.5M），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 15.4%），Carter Bankshares, Inc.自由现金流更多（$31.8M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 9.1%）
卡特银行股份有限公司是美国区域性银行控股企业，旗下运营卡特银行与信托机构，提供零售及商业银行服务，包含存款账户、个人及商业贷款、财富管理等产品，主要服务弗吉尼亚州和北卡罗来纳州的本地居民及中小商业客户。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
CARE vs RXRX — 直观对比
营收规模更大
CARE
是对方的1.1倍
$35.5M
营收增速更快
RXRX
高出666.3%
15.4%
自由现金流更多
CARE
多$79.1M
$-47.3M
两年增速更快
RXRX
近两年复合增速
9.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.8M | $35.5M |
| 净利润 | — | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 27.8% | -304.8% |
| 净利率 | — | -304.2% |
| 营收同比 | 15.4% | 681.7% |
| 净利润同比 | — | 39.6% |
| 每股收益（稀释后） | $0.38 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CARERXRX
| Q4 25 | $39.8M | $35.5M | ||
| Q3 25 | $39.1M | $5.2M | ||
| Q2 25 | $37.3M | $19.2M | ||
| Q1 25 | $37.0M | $14.7M | ||
| Q4 24 | $34.5M | $4.5M | ||
| Q3 24 | $34.2M | $26.1M | ||
| Q2 24 | $33.6M | $14.4M | ||
| Q1 24 | $33.5M | $13.8M |
净利润CARERXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $5.4M | $-162.3M | ||
| Q2 25 | $8.5M | $-171.9M | ||
| Q1 25 | $9.0M | $-202.5M | ||
| Q4 24 | — | $-178.9M | ||
| Q3 24 | $5.6M | $-95.8M | ||
| Q2 24 | $4.8M | $-97.5M | ||
| Q1 24 | $5.8M | $-91.4M |
毛利率CARERXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
营业利润率CARERXRX
| Q4 25 | 27.8% | -304.8% | ||
| Q3 25 | 18.3% | -3327.6% | ||
| Q2 25 | 28.5% | -916.8% | ||
| Q1 25 | 30.1% | -1297.9% | ||
| Q4 24 | 31.0% | -4042.4% | ||
| Q3 24 | 20.5% | -377.1% | ||
| Q2 24 | 17.6% | -697.4% | ||
| Q1 24 | 21.6% | -698.4% |
净利率CARERXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | 13.9% | -3135.3% | ||
| Q2 25 | 22.8% | -894.2% | ||
| Q1 25 | 24.2% | -1373.3% | ||
| Q4 24 | — | -3935.5% | ||
| Q3 24 | 16.4% | -367.5% | ||
| Q2 24 | 14.3% | -676.6% | ||
| Q1 24 | 17.4% | -662.4% |
每股收益（稀释后）CARERXRX
| Q4 25 | $0.38 | $-0.17 | ||
| Q3 25 | $0.24 | $-0.36 | ||
| Q2 25 | $0.37 | $-0.41 | ||
| Q1 25 | $0.39 | $-0.50 | ||
| Q4 24 | $0.36 | $-0.56 | ||
| Q3 24 | $0.24 | $-0.34 | ||
| Q2 24 | $0.21 | $-0.40 | ||
| Q1 24 | $0.25 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $419.7M | $1.1B |
| 总资产 | $4.9B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资CARERXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
总债务CARERXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益CARERXRX
| Q4 25 | $419.7M | $1.1B | ||
| Q3 25 | $412.8M | $1.0B | ||
| Q2 25 | $405.6M | $919.1M | ||
| Q1 25 | $401.8M | $933.9M | ||
| Q4 24 | $384.3M | $1.0B | ||
| Q3 24 | $386.8M | $524.6M | ||
| Q2 24 | $364.4M | $584.4M | ||
| Q1 24 | $359.1M | $401.2M |
总资产CARERXRX
| Q4 25 | $4.9B | $1.5B | ||
| Q3 25 | $4.8B | $1.4B | ||
| Q2 25 | $4.8B | $1.3B | ||
| Q1 25 | $4.7B | $1.3B | ||
| Q4 24 | $4.7B | $1.4B | ||
| Q3 24 | $4.6B | $726.5M | ||
| Q2 24 | $4.5B | $775.9M | ||
| Q1 24 | $4.6B | $557.8M |
负债/权益比CARERXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $39.9M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $31.8M | $-47.3M |
| 自由现金流率自由现金流/营收 | 79.9% | -133.1% |
| 资本支出强度资本支出/营收 | 20.2% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $54.6M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流CARERXRX
| Q4 25 | $39.9M | $-46.1M | ||
| Q3 25 | $11.8M | $-117.4M | ||
| Q2 25 | $9.6M | $-76.4M | ||
| Q1 25 | $6.4M | $-132.0M | ||
| Q4 24 | $36.9M | $-115.4M | ||
| Q3 24 | $10.3M | $-59.2M | ||
| Q2 24 | $-2.5M | $-82.2M | ||
| Q1 24 | $17.6M | $-102.3M |
自由现金流CARERXRX
| Q4 25 | $31.8M | $-47.3M | ||
| Q3 25 | $10.3M | $-117.6M | ||
| Q2 25 | $7.7M | $-79.6M | ||
| Q1 25 | $4.9M | $-133.8M | ||
| Q4 24 | $28.8M | $-116.7M | ||
| Q3 24 | $8.4M | $-63.8M | ||
| Q2 24 | $-4.3M | $-83.4M | ||
| Q1 24 | $16.3M | $-109.0M |
自由现金流率CARERXRX
| Q4 25 | 79.9% | -133.1% | ||
| Q3 25 | 26.3% | -2272.5% | ||
| Q2 25 | 20.6% | -413.9% | ||
| Q1 25 | 13.1% | -907.4% | ||
| Q4 24 | 83.5% | -2567.7% | ||
| Q3 24 | 24.6% | -244.6% | ||
| Q2 24 | -12.7% | -578.5% | ||
| Q1 24 | 48.8% | -789.9% |
资本支出强度CARERXRX
| Q4 25 | 20.2% | 3.5% | ||
| Q3 25 | 3.9% | 4.7% | ||
| Q2 25 | 5.1% | 16.4% | ||
| Q1 25 | 4.1% | 12.4% | ||
| Q4 24 | 23.6% | 28.6% | ||
| Q3 24 | 5.5% | 17.5% | ||
| Q2 24 | 5.4% | 8.2% | ||
| Q1 24 | 3.9% | 48.2% |
现金转化率CARERXRX
| Q4 25 | — | — | ||
| Q3 25 | 2.18× | — | ||
| Q2 25 | 1.13× | — | ||
| Q1 25 | 0.71× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.83× | — | ||
| Q2 24 | -0.51× | — | ||
| Q1 24 | 3.03× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
